biosurfit

biosurfit is a Portuguese in vitro diagnostics and biotechnology company developing, manufacturing, and commercializing point-of-care blood testing systems for decentralized healthcare settings. Its flagship spinit platform is a fully automated device that uses a single drop of blood and disposable discs to deliver quantitative results across multiple testing modalities, including immunoassays, hematology, and clinical chemistry. The company markets assays such as CRP, blood count, and HbA1c, and has also described a COVID-19 antibody test on the platform. In addition to its own diagnostic products, biosurfit offers contract development and manufacturing services for diagnostic cartridges, instruments, and related healthcare products. The business is best characterized as a commercial-stage diagnostics company rather than a therapeutic drug developer.